Companies /Healthcare

Johnson & Johnson

NYSE: JNJ Drug Manufacturers - General
$256.25
▲ $2.97 (+1.17%) today
Markets open · 10:59am ET

JNJ Coverage Page 67

8:05am ET
Companies and Brands

An Earnings Beat by J&J Meets Tempered 2014 Guidance

Wikimedia CommonsJohnson & Johnson (NYSE: JNJ) is out with its fourth-quarter earnings report. The pharma and consumer products giant is a key Dow Jones Industrial Average component, and shares are hanging in…

JNJ
Jon C. Ogg
4:14pm ET
Investing

The 5 Stocks That Moved the Market on Tuesday

thinkstockJanuary 7, 2014: Markets opened higher on Tuesday led by healthcare and tech stocks. The S&P 500 closed with a gain for the first time this year. The DJIA closed up 0.64%,…

Paul Ausick
4:11pm ET
Investing

The 5 Stocks That Moved the Market on Thursday

thinkstockDecember 12, 2013: Markets opened mixed on Thursday morning with the Nasdaq showing some early spunk. The DJIA remained in negative territory all day, as did the S&P 500. By the closing…

Paul Ausick
1:59pm ET
Health and Healthcare

Does the $2 Billion Settlement Jeopardize Dividends at J&J?

Wikimedia CommonsJohnson & Johnson (NYSE: JNJ) is facing a serious settlement charge-off that is somehow a victory for shareholders. J&J has had many quality control issues in recent years, but the company…

JNJ
Jon C. Ogg
8:35am ET
Health and Healthcare

Johnson & Johnson Growth Stalls

Wikimedia CommonsJohnson & Johnson (NYSE: JNJ) reported third-quarter 2013 results before markets opened Tuesday morning. The health care giant posted quarterly adjusted diluted earnings per share (EPS) of $1.36 on revenue of…

JNJ
Paul Ausick
2:36pm ET
Companies and Brands

Rolaids Back on U.S. Store Shelves

Courtesy SanofiThe U.S. division of Paris-based Sanofi (NYSE: SNY) announced on Monday that an iconic U.S. consumer product not named Twinkies is on its way back to store shelves. Over-the-counter antacid Rolaids…

Paul Ausick